4543 On Other Exchanges
Symbol
Exchange
4543 is not on other exchanges.

terumo corp (4543) Snapshot

Open
--
Previous Close
--
Day High
--
Day Low
--
52 Week High
-- - --
52 Week Low
-- - --
Market Cap
--
Average Volume 10 Days
--
EPS TTM
--
Shares Outstanding
--
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for TERUMO CORP (4543)

Related News

No related news articles were found.

terumo corp (4543) Related Businessweek News

No Related Businessweek News Found

terumo corp (4543) Details

Terumo Corporation manufactures and sells medical devices and pharmaceuticals worldwide. It provides products in the areas of cardiovascular, hospital, and blood systems. The company offers vascular intervention devices, such as introducer sheathes, guide wires, angiographic catheters, and radial artery compression devices; therapeutic devices; and intravascular imaging systems, including optical frequency domain imaging and intravascular ultrasound systems. It also provides interventional oncology devices, such as micro catheters and guide wires, micro balloon catheters, and drug-elutable beads; cardiopulmonary bypass systems comprising oxygenator with integrated arterial filters, heart-lung machines, and devices for percutaneous cardiopulmonary support system; and thoracic vascular and abdominal vascular grafts. In addition, the company offers infusion systems, including infusion pumps, closed infusion systems, and IV catheters; closed anticancer drug infusion systems; drugs and devices comprising prefilled syringes and pre-fillable syringes; pharmaceuticals and nutritional supplements; and peritoneal dialysis devices. Further, it provides analgesic and antiemetic pain management drugs; diabetes management devices; measuring device systems, such as blood glucose and blood pressure monitors, thermometers, pulse oximeters, and walking intensity and body composition monitors; and basal thermometers, fall prevention products, oral care products, urine test strips, and deodorizing devices. Additionally, the company offers automated blood collection and blood component processing systems, blood bag system with leukocyte reduction filters, pathogen reduction technology systems, centrifugal apheresis systems, cell expansion systems, and autologous cell processing devices. The company was formerly known as Sekisen Ken-onki Corporation and changed its name to Terumo Corporation in October 1974. Terumo Corporation was founded in 1921 and is headquartered in Tokyo, Japan.

20,697 Employees
Last Reported Date: 06/27/16
Founded in 1921

terumo corp (4543) Top Compensated Officers

Senior Executive Officer, Director, Chief Exe...
Total Annual Compensation: ¥168.0M
Compensation as of Fiscal Year 2016.
terumo corp
Terumo Chooses Xenex LightStrike Germ-Zapping Robots to Disinfect Healthcare Facilities & Improve Patient Safety in Japan

Terumo Corporation and Xenex Disinfection Services announced that Terumo is the exclusive distributor of Xenex LightStrike™ Germ-Zapping Robots™ in Japan. Healthcare Associated Infections (HAIs) caused by pathogens such as Clostridium difficile (C.diff), Methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE) are a global problem, and the Xenex pulsed xenon ultraviolet (UV) room disinfection technology is a proven solution that destroys these deadly microorganisms before they can pose a threat to patients and healthcare workers. The Xenex Germ-Zapping Robot has been proven effective against the Ebola virus and Anthrax, and can easily be incorporated into a facility’s disease containment and biodefense strategy. The Xenex LightStrike Germ-Zapping Robot is designed for speed, effectiveness and ease of use, which allows hospital cleaning staff to operate the robot without disrupting hospital operations. With a four- or five-minute disinfection cycle (depending on robot model), the robot can disinfect 30-62 hospital rooms per day (according to Xenex customers), including patient rooms, operating rooms, equipment rooms, emergency rooms, intensive care units and public areas. More than 400 hospitals, Veterans Affairs, Department of Defense, skilled nursing, ambulatory surgery centers and long-term acute care facilities in the U.S., Africa, Canada and Europe use Xenex robots for room disinfection.

Terumo Corporation Announces Dividend for the Second Quarter of 2017; Provides Dividend Guidance for the Fourth Quarter Ending March 31, 2017

Terumo Corporation announced dividend of ¥20.00 per share for the Second Quarter Ending March 31, 2017 against ¥19.00 per share a year ago. For the fourth quarter ending March 31, 2017, the company expects to pay dividend of ¥21.00 per share against ¥20.00 per share a year ago.

Terumo Corporation Reports Consolidated Earnings Results for the Six Months Ended September 30, 2016; Provides Earnings Guidance for the Year Ending March 2017

Terumo Corporation reported consolidated earnings results for the six months ended September 30, 2016. For the period, the company's net sales were JPY 245,110 million against JPY 259,167 million a year ago. Operating income JPY 39,370 million against JPY 39,102 million a year ago. Ordinary income JPY 30,601 million against JPY 35,758 million a year ago. Profit attributable to owners of parent JPY 20,423 million or JPY 52.49 per diluted share against JPY 27,012 million or JPY 66.90 per diluted share a year ago. Income before income taxes was JPY 30,511 million against JPY 40,362 million a year ago. For the year ending March 2017, the company expects net sales of JPY 517,000 million, operating income of JPY 75,000 million, ordinary income of JPY 65,000 million and profit attributable to owners of parent of JPY 47,500 million or JPY 130.87 per share.

 

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

4543 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 4543.
View Industry Companies
 

Industry Analysis

4543

Industry Average

Valuation 4543 Industry Range
Price/Earnings 33.8x
Price/Sales 2.7x
Price/Book 2.9x
Price/Cash Flow 32.6x
TEV/Sales 2.0x
 | 

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact TERUMO CORP, please visit www.terumo.co.jp. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.